Role of antigen-presenting cells in long-term antitumor response based on tumor-derived apoptotic body vaccination

Pathobiology

Volumn 67, Issue 5-6, 1999, Pages 306-310

  Henry, F ^a   Bretaudeau, L ^a   Hequet, A ^a   Barbieux, I ^a   Lieubeau, B ^a   Meflah, K ^a   Gregoire M ^a  

^a INSTITUT DE BIOLOGIE   (France)

Author keywords

Antigen presenting cells; Apoptotic bodies; Cancer; Cellular therapy

Indexed keywords

CLODRONIC ACID; SILICON DIOXIDE; THIOGLYCOLIC ACID; TUMOR ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER REGRESSION; CANCER SURVIVAL; CARCINOMATOSIS; CONFERENCE PAPER; CONTROLLED STUDY; DENDRITIC CELL; FLUORESCENCE ACTIVATED CELL SORTER; INFLAMMATION; MACROPHAGE; MEMORY CELL; MONOCYTE; NONHUMAN; PERITONEUM CANCER; PERITONEUM CELL; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; RAT; VACCINATION;

EID: 0342470972     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028086     Document Type: Conference Paper

References (9)

1. Perrin P, et al: An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosis. Gastroenterology 1994;107:1697-1708.
2. Hague A, et al: Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: Implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer 1993;55: 498-505.
3. Savill J: Apoptosis: Phagocytic docking without shocking. Nature 1998;392:442-443.
4. Bellone M, et al: Processing of Engulfed Apoptotic Bodies Yields T Cell Epitopes. J Immunol 1997;159:5391-5399.
5. Albert ML, et al: Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998;392:86-89.
6. Boisteau O, et al: Apoptosis induced by sodium butyrate treatment increases immunogenicity of a rat colon tumor cell line. Apoptosis 1997;2: 403-412.
7. Henry F, et al: Induction of antigen presentation by macrophages after phagocytosis of tumour apoptotic cells. Res Immunol 1998;149: 673-679.
8. Henry F, et al: Antigen-presenting cells that phagocytose apoptotic tumor-derived cells are potent tumor vaccines. Cancer Res 1999;59: 3329-3332.
9. Ronchetti A, et al: Immunogenicity of apoptotic cells in vivo: Role of antigen load, antigen-presenting cells and cytokines. J Immunol 1999;163:1230.